On December 5th, HBM HOLDINGS-B(02142) spent 1.39 million Hong Kong dollars to repurchase 100,000 shares.
Huabo Pharmaceutical Group-B (02142) announced that on December 5, 2025, the company will spend 1.392 million Hong Kong dollars to repurchase 100,000 shares, with a repurchase price of 13.63-14.25 Hong Kong dollars per share.
HBM HOLDINGS-B (02142) issued an announcement on December 5, 2025, stating that the company will spend 1.392 million Hong Kong dollars to repurchase 100,000 shares, with a repurchase price of 13.63-14.25 Hong Kong dollars per share.
Related Articles
ST TaiZhong (600169.SH) plans to transfer 100% equity of TaiZhong Coking Company to its controlling shareholder.
CITY COOLXUAN (08050): The merger of shares will take effect on December 8th.
Xinjiang Baodi Mining (601121.SH) has received approval from the Shanghai Stock Exchange for the issuance of shares and payment of cash to purchase assets.
ST TaiZhong (600169.SH) plans to transfer 100% equity of TaiZhong Coking Company to its controlling shareholder.
CITY COOLXUAN (08050): The merger of shares will take effect on December 8th.
Xinjiang Baodi Mining (601121.SH) has received approval from the Shanghai Stock Exchange for the issuance of shares and payment of cash to purchase assets.
